C. R. Bard E-Luminexx™ Biliary Stent 10mm × 80mm / 60cm Delivery System

E-Luminexx Biliary Stent 10 mm × 80 mm Price in Kenya

The Bard E-Luminexx Biliary Stent 10 mm × 80 mm is a self-expanding metallic biliary stent designed to maintain an open passage through selected malignant bile duct strictures. Manufactured under the Bard E-Luminexx range, it is intended for specialist biliary interventions performed by appropriately trained physicians.

Also known as a Bard E-Luminexx self-expanding biliary stent, 10×80 mm nitinol biliary stent, biliary self-expanding metal stent (SEMS), or E-Luminexx biliary endoprosthesis, this implant is used in the management of biliary narrowing caused by malignant tumors.

The stent is manufactured from nitinol, a nickel-titanium alloy with self-expanding properties. It is compressed within a catheter delivery system and expands toward its labeled diameter when deployed at the intended treatment site.

The specified configuration is:

BD's manufacturer catalog explicitly identifies ZBS10080 as the 10 mm × 80 mm biliary stent supplied with a 6F, 60 cm delivery catheter.

Understanding the 10/80/60 Specification

The product may appear in medical equipment catalogs as 10/80/60 Luminexx Biliary Stent.

• 10 means a nominal stent diameter of 10 mm.

• 80 means a nominal stent length of 80 mm.

• 60 means a delivery catheter length of 60 cm.

The 60 cm figure describes the delivery system, not the length of the implanted stent.

This distinction is important when purchasing biliary stents for interventional radiology departments and specialized biliary procedures.

E-Luminexx Biliary Stent Prices in Kenya

A reliable, publicly advertised Kenyan retail price for the exact Bard E-Luminexx ZBS10080 configuration could not be established.

Because biliary stents are specialist implantable medical devices, purchasing quotations should be tied to the precise catalog code and include verification of packaging integrity, sterility, expiration date, traceability, regulatory status, and delivery conditions.

The E-Luminexx biliary stent price in Kenya can vary according to the distributor, device configuration, procurement quantity, shipping, and availability.

A complete biliary stenting procedure may also involve professional fees, imaging, facility charges, and additional devices. The stent purchase price alone is not the total treatment cost.

Order Online – Bard E-Luminexx Biliary Stent Kenya

Buy the Bard E-Luminexx Biliary Stent 10 mm × 80 mm With 60 cm Delivery System through Maesio Pharmaceuticals Limited for authorized hospitals, interventional radiology departments, specialist centers, and healthcare institutions in Kenya.

Product: E-Luminexx Biliary Stent 10 mm × 80 mm (60 cm Delivery System)

Brand: Bard E-Luminexx

Manufacturer Reference: ZBS10080

Implant Material: Self-expanding nitinol

Delivery System: 6F catheter, 60 cm working length

Guidewire Compatibility: 0.035 inch, according to manufacturer instructions

Packaging: Confirm original sterile, single-use packaging

Intended Use: Specialist treatment of malignant biliary strictures according to approved labeling and clinical assessment

Delivery: Nairobi and countrywide Kenya, with East African supply arrangements subject to confirmation.

For product identification and procurement, verify the exact reference ZBS10080, required quantity, expiry date, and local availability.

An exact Maesio product-specific page could not be verified, so no unconfirmed product link is included.

Buy Bard E-Luminexx Stent With 60 cm Delivery System in Nairobi

Hospitals looking to buy Bard E-Luminexx stent 60 cm delivery system in Nairobi should confirm the stent dimensions and delivery catheter length separately.

The ZBS10080 configuration is specifically identified by its manufacturer as a 10 mm × 80 mm biliary stent with a 60 cm delivery system.

The delivery catheter length is especially relevant because it influences compatibility with the intended access route and clinical equipment.

Intended Healthcare Settings

• Specialist hospitals

• Interventional radiology departments

• Hepatobiliary treatment centers

• Tertiary referral hospitals

• Specialized surgical units

• Hospitals performing image-guided biliary interventions

Important ERCP Compatibility Distinction

A biliary stent is not automatically compatible with an ERCP endoscope simply because it is intended for the bile duct.

The Bard E-Luminexx biliary stent's manufacturer instructions describe a percutaneous transhepatic approach using fluoroscopic guidance. The 60 cm delivery catheter should not be advertised as compatible with routine transpapillary ERCP delivery unless the manufacturer expressly approves that use and the treating specialist confirms device compatibility.

Hospitals specifically seeking an ERCP-deployed biliary stent should verify whether they require a dedicated endoscopic delivery system rather than this percutaneous configuration.

E-Luminexx Self-Expanding Biliary Stent Supplier in Kenya

The E-Luminexx self-expanding biliary stent is intended for specialist healthcare facilities managing selected malignant biliary obstructions.

Maesio Pharmaceuticals Limited supplies surgical products, medical devices, hospital equipment, and specialist healthcare consumables to hospitals and medical institutions throughout Kenya and East Africa.

For procurement inquiries concerning the Bard E-Luminexx 10×80 mm biliary stent, hospitals should identify the device using its exact manufacturer reference, ZBS10080.

Customers can explore specialist medical supplies through www.maesiopharmaceuticals.co.ke.

What Hospitals Should Verify Before Procurement

• The complete Bard/BD product identification and catalog code.

• The stent diameter and length.

• The 60 cm delivery catheter specification.

• The intended percutaneous transhepatic route.

• Compatibility with the planned clinical procedure and accessories.

• Original sterile packaging and expiry date.

• Lot number and traceability information.

• Manufacturer instructions for use.

• MRI safety labeling and implant documentation.

• Applicable Kenyan medical device regulatory requirements.

• Import and distribution status.

• Institutional ordering quantities and delivery arrangements.

Bard Biliary Stent 10×80 mm for Sale in Kenya

The Bard E-Luminexx 10×80 mm Biliary Stent combines a self-expanding metallic implant with a dedicated delivery system for specialist deployment.

Self-Expanding Nitinol Construction

The nitinol mesh is compressed within the delivery catheter before placement. Following deployment, it expands toward its predetermined diameter and exerts radial force against the surrounding duct.

Open-Cell Mesh Design

BD describes the E-Luminexx biliary family as having a flexible, open-cell mesh intended to accommodate the anatomy of the treated duct.

Radiopaque Tantalum Markers

The system incorporates radiopaque Puzzle tantalum markers that facilitate visualization under fluoroscopic imaging.

Flared Stent Ends

The manufacturer describes flared ends designed to reduce migration risk and accommodate changes in lumen diameter.

Controlled Delivery System

The implant is supplied compressed within a dedicated catheter, allowing the appropriately trained physician to position and deploy it under imaging guidance.

Reduced Length Change During Deployment

The manufacturer identifies minimal length change as a design characteristic. This assists procedural planning, but actual deployed position must still be confirmed by the treating physician.

These characteristics are described in BD's official E-Luminexx biliary stent documentation.

Key Features of the Bard E-Luminexx Biliary Stent

Clinical Application: Malignant Biliary Strictures

The E-Luminexx biliary stent's stated indication is the treatment of biliary strictures resulting from malignant neoplasms.

A malignant biliary stricture is a narrowing of a bile duct associated with a cancerous process. Such narrowing can interfere with normal bile drainage.

Depending on the patient's condition, malignant biliary obstruction may be associated with jaundice, itching, infection, and other complications.

A self-expanding metallic stent may be selected as part of a specialist plan to maintain a passage through the affected duct.

Clinical Settings

Interventional radiology: Image-guided biliary stent placement through an approved access route.

Hepatobiliary care: Selected patients requiring treatment of malignant biliary strictures.

Specialist referral hospitals: Facilities equipped for advanced biliary interventions and post-procedure monitoring.

Multidisciplinary cancer care: Biliary drainage procedures may be considered within a broader treatment plan.

A stent is not a cancer treatment itself. Its function is to manage selected duct obstruction, and outcomes vary according to anatomy, disease severity, procedural success, and subsequent complications.

E-Luminexx Biliary Stent for ERCP – Compatibility Guidance

Biliary stent ERCP supplier Kenya is a relevant search phrase for hospitals sourcing devices for endoscopic biliary procedures. However, the Bard E-Luminexx ZBS10080 should not automatically be sold as an ERCP-compatible stent.

ERCP Biliary Stenting

ERCP stands for endoscopic retrograde cholangiopancreatography. It involves endoscopic access to the biliary system using specialist equipment.

Dedicated ERCP stents and their delivery systems are selected according to the endoscope's working-channel requirements and the manufacturer's approved instructions.

Percutaneous Transhepatic Biliary Stenting

A percutaneous transhepatic approach uses image-guided access through the liver to reach the biliary system.

The Bard E-Luminexx biliary stent instructions specifically describe transhepatic placement and fluoroscopic visualization.

Key Difference

Procurement recommendation: If the requesting hospital specifies ERCP, confirm the approved access route before supplying this particular product code.

E-Luminexx vs Plastic Biliary Stents

The decision between metallic and plastic biliary stents must be made by the treating specialist, not solely on purchase price.

E-Luminexx vs Covered Biliary Metal Stents

The E-Luminexx biliary stent uses an open-cell metallic mesh design and should not be described as a fully covered stent.

A covered stent is not universally better; selection depends on the treatment objective, anatomy, and device characteristics.

E-Luminexx 60 cm vs 135 cm Delivery Catheters

BD identifies different E-Luminexx product configurations with different catheter lengths.

For example, BD lists ZBL10080 as a 10 mm × 80 mm biliary stent supplied with a 135 cm delivery catheter, whereas ZBS10080 has a 60 cm delivery catheter.

A hospital should not substitute the longer catheter for the shorter one, or vice versa, without verifying the procedure's requirements and the approved product instructions.

Advantages of the E-Luminexx Biliary Stent Design

Fluoroscopic Visibility

Radiopaque markers assist the operator in identifying the stent's position during image-guided placement.

Flexible Mesh

The open-cell structure is designed to accommodate certain anatomical contours.

Self-Expanding Action

The implant expands from its compressed delivery configuration toward its nominal diameter.

Migration-Resistant Design Features

Flared ends are intended to reduce migration risk, though migration remains a recognized potential complication.

Clearly Identified Device Variants

Manufacturer catalog codes allow procurement teams to distinguish different stent dimensions and catheter lengths.

Specialist Biliary Application

The product is intended specifically for appropriately selected malignant biliary strictures, rather than generic drainage applications.

These are device design characteristics, not guarantees of procedural success.

Selecting the Correct Biliary Stent for Hospital Procurement

The treating physician is responsible for choosing the appropriate biliary stent configuration based on the patient's anatomy, clinical indication, imaging, and treatment objectives.

For procurement, the following points are essential:

1. Indication: Confirm that the proposed use matches the manufacturer's approved indications.

2. Device model: Verify Bard E-Luminexx ZBS10080.

3. Stent diameter: Confirm 10 mm.

4. Stent length: Confirm 80 mm.

5. Delivery catheter: Confirm 60 cm.

6. Catheter diameter: Confirm 6F.

7. Guidewire compatibility: Verify 0.035-inch compatibility.

8. Access route: Confirm transhepatic delivery suitability and do not assume ERCP compatibility.

9. Sterility: Check the intact original sterile barrier.

10. Expiry date: Verify sufficient remaining shelf life.

11. Lot number: Ensure implant traceability.

12. Manufacturer labeling: Obtain the applicable instructions for use.

13. MRI information: Review the device-specific MRI safety conditions.

14. Regulatory status: Confirm applicability of Kenyan importation and medical device requirements.

15. Stock and delivery: Verify availability before scheduling the procedure.

Packaging, Storage, and Handling

Original Sterile Packaging

The Bard E-Luminexx Biliary Stent is a single-use implantable device. Its packaging should remain intact until it is opened by authorized personnel for the intended procedure.

Storage Conditions

Follow the manufacturer's labeling and instructions. The available manufacturer instructions specify storage in a cool, dry, dark place.

Pre-Use Verification

Qualified clinical personnel should check the product identity, sterile packaging, expiry date, and visible condition according to the current instructions for use.

Single-Use Device

The stent system must not be reused or resterilized.

Implant Documentation

The hospital should record the product identification, lot number, and other required implant information in accordance with clinical and regulatory procedures.

MRI Considerations

MRI conditions should be checked against the specific implanted device's current manufacturer labeling. Do not assume the stent is safe under every MRI scanner setting.

Potential Complications and Clinical Precautions

Biliary stenting is an invasive specialist procedure with recognized risks. Manufacturer documentation identifies potential complications such as bleeding, infection, cholangitis, pancreatitis, stent migration, stent obstruction, malposition, and stent fracture.

Other risks may depend on the patient's condition and the access technique.

The manufacturer's instructions identify contraindications and precautions that must be assessed by the responsible physician before using the device.

This product should be selected and implanted only by appropriately trained specialists. It is not intended for patient self-use or unsupervised clinical procedures.

Frequently Asked Questions

1. What is the Bard E-Luminexx biliary stent price in Kenya?

A reliable publicly listed Kenyan price for the exact ZBS10080 model was not verified. Hospitals should request a quotation using the complete product code and specifications.

2. Where can I buy a Bard E-Luminexx biliary stent in Nairobi?

Hospitals and authorized medical facilities can inquire through Maesio Pharmaceuticals Limited regarding availability and procurement of the specified Bard stent.

3. What is the Bard E-Luminexx biliary stent?

It is a self-expanding metallic implant designed for selected malignant biliary strictures.

4. Who manufactures the E-Luminexx biliary stent?

The device is part of the Bard product range associated with BD.

5. What is the product code for the 10×80 mm, 60 cm model?

The verified manufacturer reference is ZBS10080.

6. What does 10/80/60 mean?

It indicates a 10 mm nominal stent diameter, 80 mm nominal stent length, and 60 cm delivery catheter.

7. What is the stent made from?

The implant is manufactured from self-expanding nitinol, a nickel-titanium alloy.

8. Is the E-Luminexx a self-expanding stent?

Yes. It is a self-expanding metallic stent.

9. Is the E-Luminexx biliary stent covered?

The identified E-Luminexx biliary design uses an open-cell metallic mesh and should not be described as fully covered.

10. Does the stent have radiopaque markers?

Yes. BD describes radiopaque tantalum markers designed to support fluoroscopic visualization.

11. What is the delivery catheter length?

The ZBS10080 configuration has a 60 cm delivery catheter.

12. What is the delivery catheter diameter?

The manufacturer lists a 6F catheter.

13. What guidewire size is specified?

The available device instructions specify a 0.035-inch guidewire.

14. Is the stent intended for malignant biliary obstruction?

Yes. The manufacturer's stated indication covers biliary strictures resulting from malignant neoplasms.

15. Can it be used for benign biliary strictures?

The identified biliary device's stated indication is malignant strictures. Other uses should not be assumed approved.

16. Is the E-Luminexx 60 cm stent compatible with ERCP?

Routine ERCP compatibility was not established. The manufacturer instructions describe a percutaneous transhepatic approach, so the clinical team must verify access-route compatibility.

17. What is the difference between ERCP and percutaneous biliary stenting?

ERCP uses endoscopic access through the gastrointestinal tract, while percutaneous transhepatic biliary stenting uses image-guided access through the liver.

18. Is a 60 cm catheter interchangeable with a 135 cm catheter?

No. Different catheter lengths have different procedural compatibility requirements.

19. What is the difference between ZBS10080 and ZBL10080?

Both are listed as 10×80 mm models, but ZBS10080 has a 60 cm catheter and ZBL10080 has a 135 cm catheter.

20. Does the stent require fluoroscopic imaging?

The manufacturer instructions describe placement under fluoroscopic guidance.

21. Can the stent move after placement?

Stent migration is a recognized potential complication. The design includes features intended to reduce this risk, but migration remains possible.

22. Can the stent become blocked?

Yes. Biliary stent obstruction can occur from tumor ingrowth, tumor overgrowth, sludge, or other causes.

23. Is the stent reusable?

No. It is intended for single-patient use only.

24. Can the delivery system be resterilized?

No. The manufacturer instructions prohibit reuse and resterilization.

25. Is the stent sterile when supplied?

The system is intended to be supplied in sterile packaging. The original package labeling and integrity must be checked.

26. Is the E-Luminexx stent MRI compatible?

MRI safety depends on the device-specific conditional labeling and scanner parameters. The implant documentation must be reviewed before MRI.

27. What is the stent's expected lifespan?

The clinical duration of patency varies by disease, anatomy, and complications. A universal functional lifespan should not be promised.

28. Can the stent cure bile duct cancer?

No. The stent is intended to manage selected malignant biliary obstruction, not cure the underlying malignancy.

29. What specialists use this device?

Appropriately trained specialists experienced in the approved biliary access and stenting techniques.

30. Are different E-Luminexx stent sizes available?

Yes. The manufacturer lists multiple diameters and lengths across its biliary stent family.

31. Can hospitals purchase the exact model in bulk?

Institutional purchasing arrangements depend on distributor availability, product authorization, and stock.

32. What information should appear on a procurement order?

Include the manufacturer, catalog code ZBS10080, diameter 10 mm, length 80 mm, delivery catheter 60 cm, 6F profile, quantity, and required documentation.

33. Does Maesio Pharmaceuticals supply medical products outside Nairobi?

Maesio Pharmaceuticals serves customers across Kenya and arranges East African distribution subject to product-specific requirements.

34. What should be confirmed before ordering the E-Luminexx stent?

Confirm the exact model, intended clinical use, access-route compatibility, sterility, expiry, lot traceability, regulatory requirements, and availability.

Product Specifications

The core dimensions and manufacturer product reference are supported by BD's official product catalog. Clinical use, handling, and safety must follow the current applicable instructions for use.